Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 5 , Pages 466-468 , September 2010

T1 bladder cancer: Advocating early cystectomy to improve oncologic control

References 

  1. Dalbagni G, Genega E, Hashibe M, et al. Cystectomy for bladder cancer: A contemporary series. J Urol. 2001;165:1111–1116
  2. Kurth KH, Denis L, Bouffioux C, et al. Factors affecting recurrence and progression in superficial bladder tumours. Eur J Cancer. 1995;31A:1840–1846
  3. Herr HW, Jakse G. pT1 bladder cancer. Eur Urol. 1991;20:1–8
  4. Herr HW. Does cystoscopy correlate with the histology of recurrent papillary tumours of the bladder?. BJU Int. 2001;88:683–685
  5. Brauers A, Buettner R, Jakse G. Second resection and prognosis of primary high risk superficial bladder cancer: Is cystectomy often too early?. J Urol. 2001;165:808–810
  6. Jakse G, Algaba F, Malmstrom PU, et al. A second-look TUR in T1 transitional cell carcinoma: Why?. Eur Urol. 2004;45:539–546
  7. Ghoneim MA, el-Mekresh MM, el-Baz MA, et al. Radical cystectomy for carcinoma of the bladder: Critical evaluation of the results in 1,026 cases. J Urol. 1997;158:393–399
  8. Freeman JA, Esrig D, Stein JP, et al. Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction. Cancer. 1995;76:833–839
  9. Hollenbeck BK, Miller DC, Dunn RL, et al. The effects of stage divergence on survival after radical cystectomy for urothelial cancer. Urol Oncol. 2005;23:77–81
  10. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol. 2001;19:666–675
  11. Stockle M, Alken P, Engelmann U, et al. Radical cystectomy—often too late?. Eur Urol. 1987;13:361–367
  12. Parmar MK, Freedman LS, Hargreave TB, et al. Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: Report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). J Urol. 1989;142(2 Pt 1):284–288
  13. Wasco MJ, Daignault S, Zhang Y, et al. Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection. Urology. 2007;70:69–74
  14. Kunju LP, You L, Zhang Y, et al. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens. J Urol. 2008;180:1928–1932
  15. Nadler RB, Catalona WJ, Hudson MA, et al. Durability of the tumor-free response for intravesical bacillus Calmette-Guerin therapy. J Urol. 1994;152(2 Pt 1):367–373
  16. Cookson MS, Herr HW, Zhang ZF, et al. The treated natural history of high risk superficial bladder cancer: 15-Year outcome. J Urol. 1997;158:62–67
  17. Lamm DL, Blumenstein BA, Crissman JD, et al. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1, and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group Study. J Urol. 2000;163:1124–1129
  18. Malkowicz SB, Nichols P, Lieskovsky G, et al. The role of radical cystectomy in the management of high grade superficial bladder cancer. J Urol. 1990;144:641–645

PII: S1078-1439(10)00006-2

doi: 10.1016/j.urolonc.2010.01.003

Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 5 , Pages 466-468 , September 2010

Article Tools